EXMceuticals (FRA:9OM1) Total Liabilities : €1.93 Mil (As of Mar. 2021)

View and export this data going back to 2015. Start your Free Trial

What is EXMceuticals Total Liabilities?

EXMceuticals's Total Liabilities for the quarter that ended in Mar. 2021 was €1.93 Mil.

EXMceuticals's quarterly Total Liabilities declined from Sep. 2020 (€1.81 Mil) to Dec. 2020 (€1.63 Mil) but then increased from Dec. 2020 (€1.63 Mil) to Mar. 2021 (€1.93 Mil).

EXMceuticals's annual Total Liabilities increased from Jun. 2018 (€0.13 Mil) to Jun. 2019 (€1.38 Mil) and increased from Jun. 2019 (€1.38 Mil) to Jun. 2020 (€5.64 Mil).

EXMceuticals Total Liabilities Historical Data

The historical data trend for EXMceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Total Liabilities Chart

EXMceuticals Annual Data

Trend

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Total Liabilities

Get a 7-Day Free Trial

0.01

0.07

0.13

1.38

5.64

EXMceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Total Liabilities	Get a 7-Day Free Trial															4.44	5.64	1.81	1.63	1.93

EXMceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

EXMceuticals's Total Liabilities for the fiscal year that ended in Jun. 2020 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.434	+	(0.203	+	-6.1062266354384E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	5.64

Total Liabilities	=	Total Assets (A: Jun. 2020 )	-	Total Equity (A: Jun. 2020 )
	=	0.82	-	-4.817
	=	5.64

EXMceuticals's Total Liabilities for the quarter that ended in Mar. 2021 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.918	+	(0.014	+	1.2143064331838E-17
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1.93

Total Liabilities	=	Total Assets (Q: Mar. 2021 )	-	Total Equity (Q: Mar. 2021 )
	=	0.847	-	-1.085
	=	1.93

EXMceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of EXMceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

EXMceuticals (FRA:9OM1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (FRA:9OM1) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9

Website

http://www.exmceuticals.com

EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (FRA:9OM1) Headlines

No Headlines